South Korea advances plan for National Medical Graduate School to bolster public healthcare
President Lee Jae-myeong spoke at a town hall in Cheongju’s OSCO on the event titled “Listening to Chungbuk’s Heart,” a gathering framed around regional concerns and policy priorities.
Lee used an X post to acknowledge the passage of the National Medical Graduate School Establishment Act through the National Assembly’s Health and Welfare Committee, praising the committee chair Park Joo-min of the Democratic Party for the work and the broader medical reform effort.
The bill would create a national medical graduate school to train doctors who would be obligated to serve in Korea’s public healthcare sector for 15 years after earning their medical licenses.
Park Joo-min, who chairs the Health and Welfare Committee, is also a candidate in the Democratic Party’s Seoul mayoral primary, a factor drawing attention to the president’s message.
Lee previously commented publicly in December that Jung Won-oh, the Dongjak district head and another Democratic Party Seoul mayoral primary contender, “seems capable of doing the job,” highlighting a pattern of praise for local officials under party leadership.
Beyond domestic politics, the proposed National Medical Graduate School reflects a broader debate on how to bolster public healthcare capacity and resilience. For international audiences, the move touches on how Korea aims to train and retain physicians to strengthen public health, potentially affecting healthcare delivery, regional public health cooperation, and the availability of Korea’s trained medical personnel for domestic and international collaboration.
In the U.S. context, Korea’s approach to medical education and compulsory service could influence discussions on public-health staffing, medical workforce policies, and bilateral cooperation in health technology, pharmaceuticals, and medical training. The policy’s progression through Korea’s parliament will be watched for its implications on policy planning, funding, and potential partnerships with U.S. institutions and companies in health care and life sciences.